• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童慢性肾脏病中的骨骼疾病。

Bone Disease in CKD in Children.

机构信息

Division of Pediatric Nephrology, Hospital, Universitario Central de Asturias, Avda de Roma s/n, 33011, Oviedo, Asturias, Spain.

Department of Medicine, University of Oviedo, Oviedo, Asturias, Spain.

出版信息

Calcif Tissue Int. 2021 Apr;108(4):423-438. doi: 10.1007/s00223-020-00787-z. Epub 2021 Jan 16.

DOI:10.1007/s00223-020-00787-z
PMID:33452890
Abstract

This manuscript discusses mineral and bone disorders of chronic kidney disease (MBD-CKD) in pediatric patients with special emphasis on the underlying pathophysiology, the causes and clinical profile of growth retardation, the alterations in the growth plate, the strategies to optimize growth and the medical recommendations for prevention and treatment.

摘要

本手稿讨论了慢性肾脏病(CKD)患儿的矿物质和骨代谢紊乱(MBD-CKD),特别强调了潜在的病理生理学、生长迟缓的原因和临床特征、生长板的改变、优化生长的策略以及预防和治疗的医学建议。

相似文献

1
Bone Disease in CKD in Children.儿童慢性肾脏病中的骨骼疾病。
Calcif Tissue Int. 2021 Apr;108(4):423-438. doi: 10.1007/s00223-020-00787-z. Epub 2021 Jan 16.
2
Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.成人慢性肾脏病(CKD)矿物质和骨异常(CKD-MBD)预防、诊断、评估及治疗的临床实践指南。
Nefrologia. 2013;33 Suppl 1:1-28. doi: 10.3265/Nefrologia.pre2013.Feb.11945.
3
Pediatric CKD-MBD: existing and emerging treatment approaches.儿科慢性肾脏病-矿物质和骨代谢紊乱:现有和新出现的治疗方法。
Pediatr Nephrol. 2022 Nov;37(11):2599-2614. doi: 10.1007/s00467-021-05265-8. Epub 2022 Jan 17.
4
An introduction to CKD-MBD research: restart for the future.慢性肾脏病-矿物质和骨异常研究简介:为未来重启
Clin Exp Nephrol. 2017 Mar;21(Suppl 1):1-3. doi: 10.1007/s10157-016-1372-7.
5
Mouse Models of Mineral Bone Disorders Associated with Chronic Kidney Disease.慢性肾脏病相关矿物质骨代谢紊乱的小鼠模型。
Int J Mol Sci. 2023 Mar 10;24(6):5325. doi: 10.3390/ijms24065325.
6
Mineral metabolism and cardiovascular disease in CKD.慢性肾脏病中的矿物质代谢与心血管疾病
Clin Exp Nephrol. 2017 Mar;21(Suppl 1):53-63. doi: 10.1007/s10157-016-1363-8. Epub 2017 Jan 6.
7
Current concepts and management strategies in chronic kidney disease-mineral and bone disorder.慢性肾脏病-矿物质和骨异常的当前概念与管理策略
South Med J. 2012 Sep;105(9):479-85. doi: 10.1097/SMJ.0b013e318261f7fe.
8
Adynamic bone disease: Revisited.动力性骨病:再探。
Nefrologia (Engl Ed). 2022 Jan-Feb;42(1):8-14. doi: 10.1016/j.nefroe.2022.03.005.
9
[Chronic kidney disease (CKD) and bone. The mechanisms of chronic kidney disease--mineral and bone disorder (CKD-MBD)].[慢性肾脏病与骨骼。慢性肾脏病-矿物质和骨异常(CKD-MBD)的机制]
Clin Calcium. 2009 Apr;19(4):486-92.
10
Chronic kidney disease-mineral-bone disorder: a new paradigm.慢性肾脏病-矿物质-骨异常:一种新范式。
Adv Chronic Kidney Dis. 2007 Jan;14(1):3-12. doi: 10.1053/j.ackd.2006.10.005.

引用本文的文献

1
Ultrasound Screening of Temporomandibular Joint Pathology in Children with Chronic Kidney Disease.慢性肾脏病患儿颞下颌关节病变的超声筛查
Dent J (Basel). 2025 Feb 15;13(2):84. doi: 10.3390/dj13020084.
2
[Application and considerations of recombinant human growth hormone in treating growth disorders in children with chronic kidney disease].重组人生长激素在治疗慢性肾脏病儿童生长障碍中的应用及注意事项
Zhongguo Dang Dai Er Ke Za Zhi. 2025 Feb 15;27(2):133-138. doi: 10.7499/j.issn.1008-8830.2410023.
3
Vitamin D and metabolic bone disease in prolonged continuous kidney replacement therapy: a prospective observational study.

本文引用的文献

1
Welcome and farewell.欢迎与告别。
Pediatr Nephrol. 2021 Feb;36(2):217. doi: 10.1007/s00467-020-04868-x. Epub 2020 Dec 21.
2
Strategies for Optimizing Growth in Children With Chronic Kidney Disease.优化慢性肾病患儿生长发育的策略
Front Pediatr. 2020 Jul 30;8:399. doi: 10.3389/fped.2020.00399. eCollection 2020.
3
Bone and Mineral Metabolism in Children with Nephropathic Cystinosis Compared with other CKD Entities.与其他慢性肾脏病类型相比,肾病型胱氨酸病患儿的骨与矿物质代谢情况
维生素 D 与长期连续性肾脏替代治疗中的代谢性骨病:一项前瞻性观察性研究。
BMC Nephrol. 2024 Aug 19;25(1):265. doi: 10.1186/s12882-024-03705-9.
4
Growth in children with chronic kidney disease and associated risk factors for short stature.儿童慢性肾脏病患者的生长情况及其矮小相关危险因素。
J Bras Nefrol. 2024 Oct-Dec;46(4):e20230203. doi: 10.1590/2175-8239-JBN-2023-0203en.
5
Bone Disorders in Pediatric Chronic Kidney Disease: A Literature Review.儿童慢性肾脏病中的骨骼疾病:文献综述
Biology (Basel). 2023 Nov 2;12(11):1395. doi: 10.3390/biology12111395.
6
Chest configuration in children and adolescents with infantile nephropathic cystinosis compared with other chronic kidney disease entities and its clinical determinants.儿童和青少年胱氨酸贮积症与其他慢性肾脏疾病实体的胸部特征比较及其临床决定因素。
Pediatr Nephrol. 2023 Dec;38(12):3989-3999. doi: 10.1007/s00467-023-06058-x. Epub 2023 Jul 7.
7
Mineral Metabolism in Children: Interrelation between Vitamin D and FGF23.儿童矿物质代谢:维生素 D 与 FGF23 的相互关系。
Int J Mol Sci. 2023 Apr 3;24(7):6661. doi: 10.3390/ijms24076661.
8
The clinical relevance of native vitamin D in pediatric kidney disease.儿童肾脏病中内源性维生素 D 的临床相关性。
Pediatr Nephrol. 2023 Apr;38(4):945-955. doi: 10.1007/s00467-022-05698-9. Epub 2022 Aug 5.
9
Muscle and Bone Impairment in Infantile Nephropathic Cystinosis: New Concepts.婴儿胱氨酸贮积症的肌肉骨骼损害:新概念。
Cells. 2022 Jan 5;11(1):170. doi: 10.3390/cells11010170.
10
Growth hormone treatment in the pre-transplant period is associated with superior outcome after pediatric kidney transplantation.移植前使用生长激素治疗与儿科肾移植后的良好结果相关。
Pediatr Nephrol. 2022 Apr;37(4):859-869. doi: 10.1007/s00467-021-05222-5. Epub 2021 Sep 20.
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa267.
4
Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis.西那卡塞在接受透析的继发性甲状旁腺功能亢进儿科受试者中的研究。
Pediatr Nephrol. 2020 Sep;35(9):1679-1697. doi: 10.1007/s00467-020-04516-4. Epub 2020 May 4.
5
Delayed menarche in girls with chronic kidney disease and the association with short stature.女孩慢性肾脏病初潮延迟与身材矮小的关系。
Pediatr Nephrol. 2020 Aug;35(8):1471-1475. doi: 10.1007/s00467-020-04559-7. Epub 2020 Apr 27.
6
Energy and protein requirements for children with CKD stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.能量和蛋白质需求的儿童慢性肾脏病 2-5 期和透析-临床实践建议的儿科肾脏营养工作组。
Pediatr Nephrol. 2020 Mar;35(3):519-531. doi: 10.1007/s00467-019-04426-0. Epub 2019 Dec 16.
7
Treatment of hyperphosphatemia: the dangers of aiming for normal PTH levels.治疗高磷血症:以正常 PTH 水平为目标的危害。
Pediatr Nephrol. 2020 Mar;35(3):485-491. doi: 10.1007/s00467-019-04399-0. Epub 2019 Dec 10.
8
Treatment of hyperphosphatemia: the dangers of high PTH levels.高磷血症的治疗:甲状旁腺激素水平过高的危害。
Pediatr Nephrol. 2020 Mar;35(3):493-500. doi: 10.1007/s00467-019-04400-w. Epub 2019 Nov 6.
9
Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.慢性肾脏病患者矿物质代谢标志物的纵向演变:慢性肾脏不全队列(CRIC)研究。
Am J Kidney Dis. 2020 Feb;75(2):235-244. doi: 10.1053/j.ajkd.2019.07.022. Epub 2019 Oct 23.
10
Sclerostin: a new biomarker of CKD-MBD.骨硬化蛋白:CKD-MBD 的新生物标志物。
Int Urol Nephrol. 2020 Jan;52(1):107-113. doi: 10.1007/s11255-019-02290-3. Epub 2019 Oct 14.